Image

Fixation Insitu Versus Removal for Midfoot Lisfranc Injuries

Fixation Insitu Versus Removal for Midfoot Lisfranc Injuries

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study is a multicenter prospective randomized control trial comparing hardware retention (HR) to removal of hardware (RH).

Description

Eligible patients will be randomized to one of two treatment arms: Hardware removal at 6 months or Hardware retention for a minimum of 2 years.

Consenting patients having previously undergone open reduction and internal fixation of Lisfranc injuries with an anatomic reconstruction within 6-8 weeks will be randomized to one of two treatment arms: removal hardware (RH) or hardware retention (HR).

Outcome will be assessed at 6 weeks, 12 weeks, 6 months, 1 year, and 2 years from enrollment.

Eligibility

Inclusion Criteria:

  • Subject has Lisfranc injury that was treated within 28 days of injury.
  • Subject must be enrolled in study between 6 and 8 weeks from time of initial fixation operation.
  • The patient must be medically fit for anesthesia
  • Subject is willing and able to provide written informed consent for trial participation
  • Subject is willing and able to comply with the study protocol including return for all follow-up evaluations
  • Subject may have a bony, ligamentous, or combined lisfranc injury
  • Demonstrated instability of the lisfranc complex on static, stress view or CT radiography.
  • Associated injuries - other than the lisfranc complex - are permitted provided those injuries are not deemed to significantly influence the rehabilitation or recovery of the patient at the discretion of the enrolling surgeon
  • Adequate reduction to within 1mm of lisfranc complex at time of fixation
  • Hardware across the midfoot (tarsal-metatarsal joints 1-3)

Exclusion Criteria:

  • Subject has a significant pre-existing foot injury
  • Subject has a delay in initial treatment greater than 28 days from time of injury
  • Subject has an active infection in the area of surgical approach requiring surgical debridement
  • Subject has concomitant injury which, in the opinion of the attending surgeon, is likely to impair rehabilitation or prolong fracture healing time (another long bone fracture, ipsilateral limb injury)
  • Subject has a history of rheumatoid arthritis, Diabetes, fibrous dysplasia, chronic renal failure, Paget's disease, or osteopetrosis or any other pre-existing pathologic condition affecting the Lisfranc complex
  • Subject has a high risk of death from surgery (ASA physical status Class V)
  • Subject is likely unable to maintain follow-up(no fixed address, plans to move out of town in the next year, states unable to comply with protocol, etc.)
  • Subject has cognitive impairment or language difficulties that would impede the valid completion of questionnaires
  • Subject is pregnant
  • There has been loss of fixation or reduction prior to enrollment
  • Previous corrective foot surgery
  • Associated fracture of calcaneus, talus, or tibial plafond.
  • Pathologic fracture
  • Loss of fixation or reduction prior to enrollment

Study details
    Closed Fracture Dislocation
    Tarsometatarsal Joint
    Open Fracture Dislocation
    Tarsometatarsal Joint

NCT02374944

University of Calgary

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.